Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

IDEXX Laboratories, Inc.

NASDAQ

Market Cap.

42.66B

Avg. Volume

450.92K

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze IDEXX Laboratories, Inc.!

Still processing it, give me a bit more time...

IDEXX Laboratories, Inc. News

IDEXX Laboratories, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Diagnostics & Research
idexx.com

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories, Inc. Earnings & Revenue

IDEXX Laboratories, Inc. Financials

Table Compare

Compare IDXX metrics with:

   

Earnings & Growth

IDXX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

IDXX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

IDXX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

IDXX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

IDEXX Laboratories, Inc. Income

IDEXX Laboratories, Inc. Balance Sheet

IDEXX Laboratories, Inc. Cash Flow

IDEXX Laboratories, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsNeutral
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

IDEXX Laboratories, Inc. Executives

NameRole
Mr. Jonathan J. MazelskyPresident, Chief Executive Officer & Director
Mr. Brian P. McKeonChief Financial Officer, Executive Vice President & Treasurer
Mr. Michael J. LaneExecutive Vice President and GM of Reference Laboratories & Information Technology
Ms. Sharon E. UnderbergExecutive Vice President, General Counsel, & Corporate Secretary
Mr. Michael P. JohnsonExecutive Vice President & Chief Human Resources Officer
NameRoleGenderDate of BirthPay
Mr. Jonathan J. MazelskyPresident, Chief Executive Officer & DirectorMale19612.77M
Mr. Brian P. McKeonChief Financial Officer, Executive Vice President & TreasurerMale19621.4M
Mr. Michael J. LaneExecutive Vice President and GM of Reference Laboratories & Information TechnologyMale19691.17M
Ms. Sharon E. UnderbergExecutive Vice President, General Counsel, & Corporate SecretaryFemale1961881.05K
Mr. Michael P. JohnsonExecutive Vice President & Chief Human Resources OfficerMale1978

--

IDEXX Laboratories, Inc. Insider Trades

Date17 May
NameClaflin Bruce L.
RoleDirector
TransactionDisposed
TypeS-Sale
Shares200
Date6 May
NameVandebroek Sophie V.
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares257
Date6 May
NameVandebroek Sophie V.
RoleDirector
TransactionAcquired
TypeA-Award
Shares609
Date6 May
NameVandebroek Sophie V.
RoleDirector
TransactionAcquired
TypeA-Award
Shares262
Date6 May
NameVandebroek Sophie V.
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares257
DateNameRoleTransactionTypeShares
17 MayClaflin Bruce L.DirectorDisposedS-Sale200
6 MayVandebroek Sophie V.DirectorAcquiredM-Exempt257
6 MayVandebroek Sophie V.DirectorAcquiredA-Award609
6 MayVandebroek Sophie V.DirectorAcquiredA-Award262
6 MayVandebroek Sophie V.DirectorDisposedM-Exempt257

Discover More

Streamlined Academy

IDEXX Laboratories, Inc.

NASDAQ

Market Cap.

42.66B

Avg. Volume

450.92K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

IDEXX Laboratories, Inc. News

IDEXX Laboratories, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

IDEXX Laboratories, Inc. Earnings & Revenue

IDEXX Laboratories, Inc. Income

IDEXX Laboratories, Inc. Balance Sheet

IDEXX Laboratories, Inc. Cash Flow

IDEXX Laboratories, Inc. Financials Over Time

IDEXX Laboratories, Inc. Executives

NameRole
Mr. Jonathan J. MazelskyPresident, Chief Executive Officer & Director
Mr. Brian P. McKeonChief Financial Officer, Executive Vice President & Treasurer
Mr. Michael J. LaneExecutive Vice President and GM of Reference Laboratories & Information Technology
Ms. Sharon E. UnderbergExecutive Vice President, General Counsel, & Corporate Secretary
Mr. Michael P. JohnsonExecutive Vice President & Chief Human Resources Officer
NameRoleGenderDate of BirthPay
Mr. Jonathan J. MazelskyPresident, Chief Executive Officer & DirectorMale19612.77M
Mr. Brian P. McKeonChief Financial Officer, Executive Vice President & TreasurerMale19621.4M
Mr. Michael J. LaneExecutive Vice President and GM of Reference Laboratories & Information TechnologyMale19691.17M
Ms. Sharon E. UnderbergExecutive Vice President, General Counsel, & Corporate SecretaryFemale1961881.05K
Mr. Michael P. JohnsonExecutive Vice President & Chief Human Resources OfficerMale1978

--

IDEXX Laboratories, Inc. Insider Trades

Date17 May
NameClaflin Bruce L.
RoleDirector
TransactionDisposed
TypeS-Sale
Shares200
Date6 May
NameVandebroek Sophie V.
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares257
Date6 May
NameVandebroek Sophie V.
RoleDirector
TransactionAcquired
TypeA-Award
Shares609
Date6 May
NameVandebroek Sophie V.
RoleDirector
TransactionAcquired
TypeA-Award
Shares262
Date6 May
NameVandebroek Sophie V.
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares257
DateNameRoleTransactionTypeShares
17 MayClaflin Bruce L.DirectorDisposedS-Sale200
6 MayVandebroek Sophie V.DirectorAcquiredM-Exempt257
6 MayVandebroek Sophie V.DirectorAcquiredA-Award609
6 MayVandebroek Sophie V.DirectorAcquiredA-Award262
6 MayVandebroek Sophie V.DirectorDisposedM-Exempt257

Streamlined Academy

Website screenshot
HealthcareMedical - Diagnostics & Research
idexx.com

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze IDEXX Laboratories, Inc.!

Still processing it, give me a bit more time...

IDEXX Laboratories, Inc. Financials

Table Compare

Compare IDXX metrics with:

   

Earnings & Growth

IDXX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

IDXX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

IDXX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

IDXX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

IDEXX Laboratories, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsNeutral
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Buy
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More